NCT00104637View on ClinicalTrials.gov

Sildenafil for Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Pulmonary Disease, Chronic ObstructiveEmphysema

Interventions

DRUG

sildenafil citrate

sildenafil citrate 25 mg by mouth thrice daily (po tid)

DRUG

Placebo

25 mg po tid

Trial Locations (1)

10032

Columbia Univeristy, College of Physicians and Surgeons, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Kawut, Steven, MD

INDIV